Stockscreener 앱 받기
536.09
0.67%
4.09
전일 마감가:
$532.00
열려 있는:
$533.32
하루 거래량:
81,334
Relative Volume:
0.14
시가총액:
$43.13B
수익:
$3.93B
순이익/손실:
$894.97M
주가수익비율:
49.55
EPS:
10.82
순현금흐름:
$837.70M
1주 성능:
+2.88%
1개월 성능:
+2.08%
6개월 성능:
+23.87%
1년 성능:
+13.85%
1일 변동 폭
$533.32
$539.54
1주일 범위
$513.02
$539.54
52주 변동 폭
$356.14
$549.52
아이덱스 래버러토리스 Stock (IDXX) Company Profile
명칭
Idexx Laboratories Inc
전화
(207) 556-0300
주소
ONE IDEXX DRIVE, WESTBROOK, ME
IDXX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IDXX
Idexx Laboratories Inc
|
536.32 | 42.36B | 3.93B | 894.97M | 837.70M | 10.82 |
|
TMO
Thermo Fisher Scientific Inc
|
476.36 | 157.79B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
197.44 | 138.02B | 23.82B | 3.77B | 4.90B | 5.15 |
|
A
Agilent Technologies Inc
|
119.24 | 32.08B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
190.50 | 27.28B | 15.50B | 1.33B | 2.16B | 7.34 |
아이덱스 래버러토리스 Stock (IDXX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-01 | 개시 | Jefferies | Buy |
| 2024-12-02 | 개시 | Leerink Partners | Outperform |
| 2024-07-25 | 개시 | BTIG Research | Buy |
| 2024-01-30 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2023-12-07 | 개시 | Exane BNP Paribas | Outperform |
| 2023-12-04 | 업그레이드 | Cleveland Research | Neutral → Buy |
| 2023-08-02 | 다운그레이드 | Atlantic Equities | Overweight → Neutral |
| 2022-07-25 | 다운그레이드 | Stifel | Buy → Hold |
| 2022-07-21 | 업그레이드 | Goldman | Neutral → Buy |
| 2022-07-12 | 개시 | Piper Sandler | Overweight |
| 2022-05-05 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-02-08 | 개시 | Atlantic Equities | Overweight |
| 2021-11-18 | 개시 | Morgan Stanley | Overweight |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-07-12 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-02-17 | 개시 | Barclays | Overweight |
| 2019-09-09 | 개시 | Goldman | Neutral |
| 2019-05-23 | 개시 | Guggenheim | Buy |
| 2018-11-02 | 재확인 | BofA/Merrill | Buy |
| 2018-05-07 | 재확인 | Stifel | Buy |
| 2018-01-16 | 개시 | Piper Jaffray | Overweight |
| 2017-08-23 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2017-07-28 | 업그레이드 | CL King | Neutral → Buy |
| 2017-02-03 | 다운그레이드 | Feltl & Co. | Hold → Sell |
| 2016-09-29 | 재개 | BofA/Merrill | Neutral |
| 2016-08-16 | 재확인 | Stifel | Buy |
| 2016-08-03 | 업그레이드 | Northcoast | Sell → Neutral |
| 2016-07-20 | 재확인 | Canaccord Genuity | Buy |
| 2016-04-19 | 재확인 | Canaccord Genuity | Buy |
| 2016-04-01 | 개시 | CL King | Neutral |
| 2016-03-21 | 재확인 | Stifel | Buy |
| 2016-02-04 | 개시 | Credit Suisse | Outperform |
| 2015-10-29 | 재확인 | Stifel | Buy |
| 2015-08-28 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2015-08-13 | 재확인 | Stifel | Buy |
| 2015-07-23 | 재확인 | Canaccord Genuity | Buy |
모두보기
아이덱스 래버러토리스 주식(IDXX)의 최신 뉴스
At US$532, Is IDEXX Laboratories, Inc. (NASDAQ:IDXX) Worth Looking At Closely? - simplywall.st
IDEXX Laboratories Inc. Stock Analysis and ForecastFree Stock Market Query - Autocar Professional
What drives IDEXX Laboratories Inc. stock priceUnmatched market gains - jammulinksnews.com
Is IDEXX Laboratories Inc. a good long term investmentMarket-leading profit generation - jammulinksnews.com
What analysts say about IDEXX Laboratories Inc. stockUnmatched profit growth - jammulinksnews.com
Should You Consider Adding IDEXX Laboratories (IDXX) to Your Portfolio? - Yahoo Finance
IDEXX Laboratories Inc. Surges to 413th in Trading Volume with $253 Million in Shares Traded - AInvest
Here's What to Expect From IDEXX Laboratories' Next Earnings Report - MSN
Agree To Buy Idexx Laboratories At $490, Earn 9.8% Annualized Using Options - Nasdaq
IDEXX Laboratories (NASDAQ:IDXX) Stock Price Expected to Rise, Leerink Partners Analyst Says - MarketBeat
How high can IDEXX Laboratories Inc. stock price go in 20253x Return Stock Radar - beatles.ru
Leerink Partners Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Raises Target Price to $600 - 富途牛牛
Expert Outlook: IDEXX Laboratories Through The Eyes Of 6 Analysts - 富途牛牛
**IDEXX Laboratories: A High-Quality Business with Strong Fundamentals and Attractive Long-Term Growth Prospects** - AInvest
IDEXX Laboratories, Inc.: A Business With Very Strong Fundamentals (NASDAQ:IDXX) - Seeking Alpha
Idexx Laboratories (IDXX) Sees Raised Price Target from Leerink Analyst | IDXX Stock News - GuruFocus
Are Robust Financials Driving The Recent Rally In IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Stock? - 富途牛牛
Here's What To Expect From IDEXX Laboratories' Next Earnings Report - Barchart.com
IDEXX Laboratories Expands Board with New Director - The Globe and Mail
IDEXX Laboratories (IDXX) Announces Election of New Independent Director - GuruFocus
IDEXX Laboratories Appoints Joseph L. (Jay) Hooley To Board - citybiz
IDEXX Laboratories Elects Joseph L. (Jay) Hooley to Board of Directors - AInvest
STOK files 8-K; releases data guiding Phase 3 EMPEROR dosing | IDXX SEC FilingForm 8-K - Stock Titan
What Does IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Share Price Indicate? - Yahoo Finance
Here's How Much You'd Have If You Invested $1000 in Idexx Laboratories a Decade Ago - Yahoo Finance
IDEXX Laboratories Insiders Sell US$2.4m Of Stock, Possibly Signalling Caution - simplywall.st
Here's How Much You Would Have Made Owning IDEXX Laboratories Stock In The Last 20 Years - Benzinga
Stifel Nicolaus Issues Positive Forecast for IDEXX Laboratories (NASDAQ:IDXX) Stock Price - MarketBeat
IDEXX Laboratories (NASDAQ:IDXX) Coverage Initiated by Analysts at Jefferies Financial Group - MarketBeat
Idexx Laboratories stock hits 52-week high at $546.61 By Investing.com - Investing.com South Africa
Idexx Laboratories stock hits 52-week high at $546.61 - Investing.com
IDEXX Laboratories (IDXX) Price Target Raised by Stifel | IDXX Stock News - GuruFocus
(PDF) Performance comparison of SNAP® 4Dx® plus and AccuPlex®4 for the detection of antibodies to Borrelia burgdorferi and Anaplasma phagocytophilum - researchgate.net
Stifel Adjusts Price Target on IDEXX Laboratories to $540 From $510, Maintains Hold Rating - MarketScreener
Investing in IDEXX Laboratories (NASDAQ:IDXX) Five Years Ago Would Have Delivered You a 58% Gain - 富途牛牛
IDEXX Laboratories, Inc.(NasdaqGS: IDXX) dropped from Russell 1000 Dynamic Index - MarketScreener
(PDF) Validation of immune complex dissociation methods for use with heartworm antigen tests - researchgate.net
What Makes IDEXX Laboratories (IDXX) a Good Investment? - Insider Monkey
IDEXX Laboratories to Release 2025 Second Quarter Financial Results | IDXX Stock News - GuruFocus
Idexx Laboratories stock hits 52-week high at $530.74 - Investing.com
IDEXX Laboratories (IDXX) Price Target Hiked to $580 at Leerink Partners - Insider Monkey
아이덱스 래버러토리스 (IDXX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.40%
0.70%
자본화:
|
볼륨(24시간):